These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7784124)

  • 1. A commercial vaccine for ovine toxoplasmosis.
    Buxton D; Innes EA
    Parasitology; 1995; 110 Suppl():S11-6. PubMed ID: 7784124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Western blot analysis of the IgG response of sheep vaccinated with S48 Toxoplasma gondii (Toxovax).
    Wastling JM; Harkins D; Buxton D
    Res Vet Sci; 1994 Nov; 57(3):384-6. PubMed ID: 7871261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine.
    Buxton D; Thomson KM; Maley S; Wright S; Bos HJ
    Vet Rec; 1993 Sep; 133(13):310-2. PubMed ID: 8236665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of interferon gamma production in vivo during infection with the S48 vaccine strain of Toxoplasma gondii.
    Innes EA; Panton WR; Thomson KM; Maley S; Buxton D
    J Comp Pathol; 1995 Jul; 113(1):89-94. PubMed ID: 7490343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines against Toxoplasma gondii: new developments and perspectives.
    Zhang NZ; Chen J; Wang M; Petersen E; Zhu XQ
    Expert Rev Vaccines; 2013 Nov; 12(11):1287-99. PubMed ID: 24093877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in developing vaccines against Toxoplasma gondii: an update.
    Zhang NZ; Wang M; Xu Y; Petersen E; Zhu XQ
    Expert Rev Vaccines; 2015; 14(12):1609-21. PubMed ID: 26467840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant.
    Buxton D; Thomson K; Maley S; Wright S; Bos HJ
    Vet Rec; 1991 Aug; 129(5):89-93. PubMed ID: 1926725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of lambs with the S48 strain of Toxoplasma gondii reduces tissue cyst burden following oral challenge with a complete strain of the parasite.
    Katzer F; Canton G; Burrells A; Palarea-Albaladejo J; Horton B; Bartley PM; Pang Y; Chianini F; Innes EA; Benavides J
    Vet Parasitol; 2014 Sep; 205(1-2):46-56. PubMed ID: 25062897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154.
    Hiszczyńska-Sawicka E; Li H; Xu JB; Holec-Gąsior L; Kur J; Sedcole R; Bickerstaffe R; Stankiewicz M
    Vet Parasitol; 2011 Dec; 183(1-2):72-8. PubMed ID: 21742437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice.
    Gong P; Cao L; Guo Y; Dong H; Yuan S; Yao X; Ren W; Yao L; Xu Z; Sun Q; Zhang X
    Exp Parasitol; 2016 Jul; 166():131-6. PubMed ID: 27059254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the local and systemic antibody response to primary and secondary infection with S48 Toxoplasma gondii in sheep.
    Wastling JM; Harkins D; Maley S; Innes E; Panton W; Thomson K; Buxton D
    J Comp Pathol; 1995 Jan; 112(1):53-62. PubMed ID: 7722008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovine toxoplasmosis.
    Innes EA; Bartley PM; Buxton D; Katzer F
    Parasitology; 2009 Dec; 136(14):1887-94. PubMed ID: 19995468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to reduce transmission of Toxoplasma gondii to animals and humans.
    Dubey JP
    Vet Parasitol; 1996 Aug; 64(1-2):65-70. PubMed ID: 8893464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.
    Rahimi MT; Sarvi S; Sharif M; Abediankenari S; Ahmadpour E; Valadan R; Ramandie MF; Hosseini SA; Daryani A
    Parasitol Res; 2017 Feb; 116(2):609-616. PubMed ID: 27909791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination concepts against Toxoplasma gondii.
    Garcia JL
    Expert Rev Vaccines; 2009 Feb; 8(2):215-25. PubMed ID: 19196201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.
    Stanley AC; Buxton D; Innes EA; Huntley JF
    Vaccine; 2004 Sep; 22(29-30):3929-41. PubMed ID: 15364441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal vaccination against toxoplasmosis.
    Bout D; Buzoni-Gatel D; Chardès T; Debard N; Mevelec MN
    Vet Res; 1995; 26(3):214-5. PubMed ID: 7795682
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of Toxoplasma gondii vaccine: A global challenge.
    Verma R; Khanna P
    Hum Vaccin Immunother; 2013 Feb; 9(2):291-3. PubMed ID: 23111123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii.
    Hiszczyńska-Sawicka E; Olędzka G; Holec-Gąsior L; Li H; Xu JB; Sedcole R; Kur J; Bickerstaffe R; Stankiewicz M
    Vet Parasitol; 2011 May; 177(3-4):281-9. PubMed ID: 21251760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.